Skip to Content

Tag: Philips


News

In brief: React Health and Rotech CEOs, Philips medical device reports 

February 7, 2024HME News Staff

SARASOTA, Fla. – React Health has appointed Bill Shoop, most recently vice president and general manager of ResMed North America, as its CEO.  “I am extremely excited about the opportunity to join this experienced and talented team,” he said. “I believe React Health is very well positioned to help the industry and continue to advance our mission of delivering innovative solutions that positively impact patients’ lives and the people that care for them.”  Shoop,...

CPAP Device, Philips, React Health, Rotech Healthcare


Read Full Articlered right arrow icon

Also Noted

Philips sends more MDRs to FDA 

February 5, 2024HME News Staff

WASHINGTON – Philips has submitted more than 7,000 medical device reports, including 111 reports of death, for July 1, 2023, to Sept. 30, 2023, that are associated with the breakdown or suspected breakdown of the foam used in the ventilators and BiPAP and CPAP devices included in its large recall, according to the U.S. Food and Drug Administration. Since April 2021, the company has submitted more than 116,000 MDRs, including 561 reports of death, reportedly associated with the breakdown or...

medical device reports, Philips, Recall


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Philips now has ‘clarity’ to rebuild 

January 31, 2024Liz Beaulieu, Editor

AMSTERDAM – With a consent decree nearly finalized and a more streamlined product portfolio, Philips believes its sleep and respiratory care business “bottomed out” at EUR 1 billion in revenues for 2023 and will "build back from there,” says CEO Roy Jakobs.  The company announced on Jan. 29 that it has agreed on the terms of a consent decree with the U.S. Food and Drug Administration related to Philips Respironics and its recall of certain sleep and respiratory...

Consent Decree, CPAP Recall, Philips, Roy Jakobs


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Philips agrees to terms of consent decree 

January 29, 2024HME News Staff

AMSTERDAM – Philips has agreed on the terms of a multi-year consent decree with the U.S. Food and Drug Administration related to Philips Respironics and its recall of certain sleep and respiratory care devices, providing clarity and a roadmap to demonstrate compliance and to restore the business, the company says.  In the U.S., Respironics will continue to service sleep and respiratory care devices already with health care providers and patients, and supply accessories (including patient...

Consent Decree, Philips, Philips Respironics, Recall


Read Full Articlered right arrow icon

Vendors

Philips countersues SoClean 

January 5, 2024HME News Staff

PITTSBURGH – Philips on Jan. 5 filed a counter lawsuit against SoClean and its private equity owner, DWHP, arguing they "recklessly and unlawfully” marketed their ozone cleaning devices as compatible with its CPAP and BiPAP devices.  “Contrary to SoClean’s repeated representation of compatibility, SoClean knew that its ozone cleaners had the potential to eat away at Philips Respironics’ PAPs from the inside,” the company states in the lawsuit filed...

ozone cleaning, Philips, Philips Recall, SoClean


Read Full Articlered right arrow icon

News

In brief: Philips settlement, Compass Health network, NHIA fellows 

December 27, 2023HME News Staff

SAN DIEGO – Philips Respironics has paid almost $2.5 million to resolve allegations that it violated the False Claims Act by giving kickbacks to sleep laboratories, the U.S. Attorney’s Office for the Southern District of California has announced.  The settlement resolves allegations that, from 2016 through 2021, Philips Respironics provided sleep labs with free masks used to treat and diagnose sleep-related respiratory disorders to induce physicians at the labs to write referrals...

Compass Health Brands, Kickbacks, National Home Infusion Association (NHIA), Philips, Quality Biomedical


Read Full Articlered right arrow icon

Also Noted

Philips posts FAQ on silicone foam 

December 26, 2023HME News Staff

AMSTERDAM – Philips posted a new FAQ to its website on Dec. 22 that explains the use of silicone sound abatement foam in its DreamStation 2 and other sleep and respiratory devices that were remediated as part of its June 2021 recall. “We have received a number of questions about the silicone sound abatement foam used in repaired and new replacement devices, as well as widely in the industry,” the company states. “We believe it is important that patients, care providers...

CPAP Recall, Philips, silicone, Sound Abatement Foam


Read Full Articlered right arrow icon

Vendors

Philips settles kickback allegations 

December 26, 2023HME News Staff

SAN DIEGO – Philips Respironics has paid almost $2.5 million to resolve allegations that it violated the False Claims Act by giving kickbacks to sleep laboratories, the U.S. Attorney’s Office for the Southern District of California has announced.  The settlement resolves allegations that, from 2016 through 2021, Philips Respironics provided sleep labs with free masks used to treat and diagnose sleep-related respiratory disorders to induce physicians at the labs to write referrals...

Kickbacks, Philips


Read Full Articlered right arrow icon

Also Noted

Philips moves forward with share repurchase  

December 19, 2023HME News Staff

AMSTERDAM – Philips has completed the cancelation of about 15.1 million of its shares. The canceled shares were acquired as part of the EUR 1.5 million share repurchase program for capital reduction purposes that was previously announced on July 26, 2021. Philips will complete the share repurchase program in April 2024, resulting in a further cancelation of 4.4 million shares in the second quarter of 2024. The company’s current issued share capital amounts to about EUR 182.7 million,...

Philips, share repurchase


Read Full Articlered right arrow icon

News

In brief: Teufel’s new job, FDA’s new warning, Joerns’ new direction 

December 1, 2023HME News Staff

NASHVILLE, Tenn. — National Seating & Mobility has named Crispin Teufel, who served as CEO of Lincare Holding for five years, as its CEO.  Teufel replaces Chuck Bodner, who had been serving as interim CEO. Bodner will continue in his role as CFO.  “I am honored to take on the role of CEO at NSM,” Teufel said. “The passion and perseverance of the NSM team is evidenced by the company’s continued success. I am proud to support the NSM team in further advancing...

CPAP, Crispin Teufel, DreamStation 2, Joerns, Lincare, National Seating & Mobility (NSM), Philips


Read Full Articlered right arrow icon